Spesana
Spesana, a biotech firm, streamlines healthcare with AI and automation, optimizing diagnostics, patient records, and data management.
Founded
2020Spesana, a biotech firm, streamlines healthcare with AI and automation, optimizing diagnostics, patient records, and data management.
Founded in 2019, Spesana is a biotechnology company dedicated to revolutionizing healthcare through AI and automation. With a mission to optimize diagnostics, patient records, and data management, Spesana offers a comprehensive healthcare platform designed for health systems, molecular labs, biopharma, and revenue cycle stakeholders. Their platform streamlines the ordering of molecular diagnostics, aggregates patient records, generates instant MD referrals, and supports fully electronic tumor boards with data submissions to registrars.
Notable for its team that previously built the first oncology EMR and clinical decision support system, which was sold to GV-backed Flatiron Health, Spesana has attracted significant attention in the biotech industry. The company has achieved key milestones in creating an interoperability overlay that integrates healthcare data at the point of care. By enhancing existing workflows with digital tools, Spesana has made a substantial impact on providers, payers, life science partners, and patients, making healthcare better, faster, and smarter.
Companies similar to Spesana include Healthspek, SpIntellx, Spektron Systems and Spes Pharmaceuticals.
Spesana was founded in 2020.
Spesana's headquarters is located in Memphis, TN, US.
Spesana's most recent funding round was for $350k (USD) in May 2022.
As of May 27, 2022, Spesana has disclosed funding of $350k (USD). Undisclosed round amounts are excluded.
Spesana has 26 employees as of Feb 5, 2024.
Spes Pharmaceuticals
spespharma.com
